Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Geriatric medicine

Beta-blockers risk functional decline in some older patients

Nursing home residents with pre-existing cognitive or functional impairments were at a higher risk of functional decline after taking beta-blockers following acute myocardial infarction, study shows.

Beta-blockers are a cornerstone of treatment following acute myocardial infarction, but many older nursing home residents don’t receive them owing to concerns over functional harms, such as dizziness, fatigue and depression.

Reporting their findings in JAMA Internal Medicine[1] (online, 12 December 2016), researchers studied 5,496 nursing home residents who began taking a beta-blocker after an acute myocardial infarction, matched to an equal number of residents with similar characteristics who did not receive beta-blockers.

Among those with pre-existing substantial cognitive or functional impairment, beta-blocker users had a 34% increased risk of functional decline. But functional decline was unaffected by beta-blocker use in those with relatively preserved baseline cognition and function. Mortality was 26% lower in beta-blocker users and this was similar across all subgroups.

The researchers conclude that this trade-off between functional harms and mortality benefits should be resolved on individual patient preferences rather than generally withholding beta-blocker treatment for older patients.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2017.20202217

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy is a practical handbook for learning and teaching sociology and psychology, and applying this to pharmacy practice.

    £32.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • Nurse Prescribers' Formulary

    Nurse Prescribers' Formulary

    Essential reference for Community Practitioner Nurse Prescribers. Provides an overview of common conditions and details of medicines that may be prescribed.

    £17.99Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £32.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close-up of pills on an elderly person's hands

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.